Literature DB >> 16427785

Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells.

Michael Fritzenwanger1, Friedhelm Kuethe, Daniela Haase, Enrico Jandt, Hans-R Figulla.   

Abstract

In chronic heart failure (CHF) cardiotrophin-1 (CT-1) and monocyte chemoattractant protein-1 (MCP-1) plasma concentrations are elevated. CT-1 is a cytokine of the interleukin-6 (IL-6) superfamily. Most members of the IL-6 family are able to activate human umbilical vein endothelial cells (HUVEC) but so far there are no data which demonstrate that CT-1 can activate HUVEC. Because MCP-1-as a marker of endothelial activation-is elevated in CHF we examined whether CT-1 will induce MCP-1 production in HUVEC. MCP-1 mRNA levels were determined by real time PCR, RT-PCR and northern blot analysis and MCP-1 protein concentrations in the supernatant by ELISA. Signal transducer and activator of transcription 3 (STAT3) and phosphorylated STAT3 (pSTAT3) were investigated by western blot analysis. Incubation of HUVEC with different CT-1 concentrations for various time periods induced time and concentration dependent MCP-1 mRNA. Maximal MCP-1 mRNA was reached after 6h. After 24h CT-1 caused a significant induction of MCP-1 protein in the supernatant compared to control. CT-1 induced concentration dependent phosphorylation of STAT3 without any change in total-STAT3 concentration. Piceatannol-a specific blocker of STAT3 phosphorylation-inhibited CT-1 induced MCP-1 induction completely. AG490-a blocker of the JAK2 pathway-was also able to inhibit CT-1 induced MCP-1 upregulation, indicating that the JAK2 pathway is also necessary for MCP-1 induction. Parthenolide-a blocker of NFkappaB-inhibited CT-1 induced MCP-1 expression, completely. Our data show that CT-1 induces in a concentration and time dependent manner MCP-1 mRNA and protein in HUVEC. STAT3 phosphorylation, the activation of JAK2 and NF-kappaB are involved in this pathway. In CHF, CT-1 may be able to induce MCP-1 which might be responsible for progression of heart failure either by recruiting inflammatory cells within the myocardium or by a direct modulation of myocyte function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427785     DOI: 10.1016/j.cyto.2005.11.016

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

Review 1.  STAT3 and Endothelial Cell-Cardiomyocyte Dialog in Cardiac Remodeling.

Authors:  Fouad A Zouein; George W Booz; Raffaele Altara
Journal:  Front Cardiovasc Med       Date:  2019-04-24

2.  Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive.

Authors:  Carlos Zgheib; Mazen Kurdi; Fouad A Zouein; Barak W Gunter; Brian A Stanley; Joe Zgheib; Damian G Romero; S Bruce King; Nazareno Paolocci; George W Booz
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

3.  A polymeric nanomedicine diminishes inflammatory events in renal tubular cells.

Authors:  Alvaro C Ucero; Sergio Berzal; Carlos Ocaña-Salceda; Mónica Sancho; Mar Orzáez; Angel Messeguer; Marta Ruiz-Ortega; Jesús Egido; María J Vicent; Alberto Ortiz; Adrián M Ramos
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.